Production & Manufacturing
Production & Manufacturing
Capsugel Expands Capabilities for Early-Phase Development through Commercial Manufacturing across Multiple Locations in Europe
Capsugel, a global leader in delivering high-quality, innovative dosage forms and solutions, announced that it is expanding the technology platforms and capabilities at its product development and manufacturing sites in Edinburgh, Scotland, and Ploërmel and Strasbourg, France. ...
Production & Manufacturing
FDA Approves Janssen’s STELARA for Treatment of Adults With Moderately to Severely Active Crohn’s Disease
Janssen Biotech Inc announced that the U.S. FDA has approved STELARA® (ustekinumab) for the treatment of moderately to severely active Crohn’s disease in adults (18 years or older) who have failed or were intolerant to treatment with immunomodulators or...
Production & Manufacturing
Alcon launches the NGENUITY® 3D Visualization System designed to further enhance retinal surgeon experience
Alcon, the global leader in eye care and a division of Novartis, launches the NGENUITY® 3D Visualization System, a platform for Digitally Assisted Vitreoretinal Surgery (DAVS).  The system is designed to enhance visualization of the back of the eye...
Production & Manufacturing
GSK announces positive real-world data for meningitis B vaccine in first year since UK immunisation programme
Preliminary data from the world’s first national meningitis B immunisation programme with Bexsero1, launched one year ago in the UK, shows the estimated effectiveness of the vaccine at 83 percent against any meningitis B strain and 94 percent. ...
Production & Manufacturing
Dr. Reddy’s Laboratories announces the launch of Bupropion HCl Extended-Release Tablets
Dr. Reddy’s Laboratories Ltd announced that it has launched Bupropion HCl extended-release tablets, USP (SR) in 100 mg, 150 mg and 200 mg, a therapeutic equivalent generic version of Wellbutrin® SR (bupropion HCl) Sustained-Release Tablets in the United States...
Production & Manufacturing
AstraZeneca enters commercialisation agreement with Aspen for  anaesthetics portfolio
AstraZeneca announced that it has completed the commercialisation agreement with Aspen Global Incorporated (AGI), part of the Aspen Group, for rights to its global anaesthetics portfolio outside the US. The agreement covers seven established medicines -...
Production & Manufacturing
TaiGen Biotechnology Out-Licenses Taigexyn® (Nemonoxacin) to Productos CientÃficos for the Latin American Market
TaiGen Biotechnology Company, Limited announced that they have signed an exclusive licensing agreement with Productos CientÃficos S.A. de C.V. ("PC"), a leading Mexican pharmaceutical company, to develop and commercialize Taigexyn® (nemonoxacin) in Latin America. Taigexyn® is...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read